Wednesday, 17 April 2013

Advanced Cell Technology to Present at Regen Med Investor Day

ACT today announced that Gary Rabin, CEO and Chairman of ACT, will represent the company at the 1st annual Regen Med Investor Day this Wednesday in New York City.

Regen Med Investor Day is a one-day, closed to the public event organized by the Alliance for Regenerative Medicine (ARM) in partnership with financial firms Burrill & Company, Maxim Group and Piper Jaffray.

Interview with Gary Rabin 

You can read more about the upcoming event here and here

No comments:

Post a Comment

Please note that we dont offer any kind of medical advice. Questions requesting specific medical advice (e.g. where can I get this treatment, will this cure XXX condition, etc) will be published but most probably ignored by the administrators. :)

Note to spammers: You shall not pass. If you really want a link from us then consider making a stem cell related guest post !